---
title: CRO Daily News — November 10, 2026
slug: daily-news-2026-11-10-cro
site: cro
post_kind: news
byline: BioBM
description: November 10 CRO daily: Quanticate Strengthens Leadership in Clinical Data Management with New VP Appointment; Insights from Large Pharma on Navigating APAC…
canonical_url: https://www.cro.directory/posts/daily-news-2026-11-10-cro
published_at: 2026-11-10T23:59:46.799Z
last_updated: 2026-11-11T00:01:04.011Z
---

### [Quanticate](/companies/quanticate) Strengthens Leadership in Clinical Data Management with New VP Appointment
- [Quanticate](/companies/quanticate) has appointed Praveen Arockiaraj as Vice President and Head of Clinical Data Management in Bangalore, India.
- Arockiaraj brings over 22 years of experience in clinical data management and has previously held senior roles at [Labcorp](/companies/labcorp) and ICON Clinical Research.

**Operational Impact**

Arockiaraj's leadership is expected to bolster [Quanticate](/companies/quanticate)'s capabilities in managing complex clinical development programs for pharmaceutical clients.

*Source: [Contract Pharma Breaking News RSS](https://www.contractpharma.com/breaking-news/quanticate-appoints-praveen-arockiaraj-as-vp-head-of-clinical-data-management)*

---

### Insights from Large Pharma on Navigating APAC for Phase III Trials
- APAC has become increasingly attractive for global Phase III trials due to faster recruitment and lower costs.
- China's approval timelines have significantly improved, with some reviews taking as little as 30 days under risk-sharing conditions.

**Operational Impact**

Smaller biotechs must adapt their strategies for APAC trials by aligning site selection with marketing plans and partnering with experienced CROs.

*Source: [Applied Clinical Trials RSS](https://www.appliedclinicaltrialsonline.com/view/large-pharma-apac-smaller-biotechs-learning)*

---

### [Perceptive](/companies/perceptive) Discovery Enhances Operations with New VP to Drive Growth in Preclinical Research
- [Perceptive](/companies/perceptive) Discovery has appointed Dr. Benjamin Bronfin as Vice President of Operations to enhance operational efficiency and service delivery.
- Dr. Bronfin brings over 25 years of experience in CROs and will focus on building scalable infrastructure to support growth in oncology and radioligand therapy.

**Operational Impact**

Dr. Bronfin's appointment is expected to improve operational processes and support [Perceptive](/companies/perceptive) Discovery's expansion in preclinical and translational research services.

*Source: [PR Newswire pharma category RSS](https://www.prnewswire.com/news-releases/perceptive-discovery-appoints-dr-benjamin-bronfin-as-vice-president-of-operations-to-support-continued-growth-and-operational-excellence-302935252.html)*

## References

1. [Contract Pharma Breaking News RSS — Quanticate Strengthens Leadership in Clinical Data Management with New VP Appointmen](https://www.contractpharma.com/breaking-news/quanticate-appoints-praveen-arockiaraj-as-vp-head-of-clinical-data-management)
2. [Applied Clinical Trials RSS — Insights from Large Pharma on Navigating APAC for Phase III Trials](https://www.appliedclinicaltrialsonline.com/view/large-pharma-apac-smaller-biotechs-learning)
3. [PR Newswire pharma category RSS — Perceptive Discovery Enhances Operations with New VP to Drive Growth in Preclinical Re](https://www.prnewswire.com/news-releases/perceptive-discovery-appoints-dr-benjamin-bronfin-as-vice-president-of-operations-to-support-continued-growth-and-operational-excellence-302935252.html)

Source: https://www.cro.directory/posts/daily-news-2026-11-10-cro